Expression of NAG-1, a Transforming Growth Factor-β Superfamily Member, by Troglitazone Requires the Early Growth Response Gene EGR-1
Open Access
- 1 February 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (8), 6883-6892
- https://doi.org/10.1074/jbc.m305295200
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Peroxisome proliferator‐activated receptor γ ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell linesCancer, 2002
- Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomasNature Medicine, 2002
- Troglitazone Inhibits Growth of MCF-7 Breast Carcinoma Cells by Targeting G1 Cell Cycle RegulatorsBiochemical and Biophysical Research Communications, 2001
- PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoterFEBS Letters, 1998
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activationNature, 1998
- PPAR-γ agonists inhibit production of monocyte inflammatory cytokinesNature, 1998
- The Organization, Promoter Analysis, and Expression of the Human PPARγ GenePublished by Elsevier BV ,1997
- Peroxisome proliterator-activated receptors, orphans with ligands and functionsCurrent Opinion in Lipidology, 1997
- Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptorProceedings of the National Academy of Sciences of the United States of America, 1997
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with TroglitazoneNew England Journal of Medicine, 1994